Medical experts gather in Guangzhou

The 9th Biomedical Innovation and Investment Conference was held in Guangzhou from Nov 30 to Dec 1.

To gain a deeper understanding of the layout of the biopharmaceutical industry in Guangzhou, the conference arranged visits to Guangzhou International Bio Island and the Sino-Singapore Guangzhou Knowledge City, attracting 60 global companies and institutions. Participants were very impressed by the biopharmaceutical development environment in Guangzhou.

During the conference, participants closely followed the top-level planning of the Guangdong-Hong Kong-Macao Greater Bay Area and discussed opportunities to promote high-quality development in biopharmaceuticals.

Experts emphasized that biopharmaceuticals are an important component of new productive forces and will become a key emerging manufacturing industry for national development in the future. They stressed the need to fortify commercial health insurance, positioning China to transition from a mere pharmaceutical power to an absolute powerhouse.

Guangzhou boasts abundant medical resources and a strong business environment, providing ample space for medical innovation. The Guangzhou Development District stands out as a top biopharmaceutical hub, gathering over 4,000 biopharmaceutical companies such as AstraZeneca, Thermo Fisher, BeiGene, Akeso, and Hengrui Medicine, forming a complete industrial chain.

The rapid development of the biopharmaceutical industry in Guangzhou is also benefiting from the support of State-owned investment platforms, providing solid capital guarantees for innovation in biomedical technology and industrial development in the Greater Bay Area.

Guangzhou International Bio island. [Photo/WeChat account: guangzhougaoxinqu]

Share - WeChat